Literature DB >> 11242140

Myeloid-related protein (MRP)-8 from cervico-vaginal secretions activates HIV replication.

F B Hashemi1, J Mollenhauer, L D Madsen, B E Sha, W Nacken, M B Moyer, C Sorg, G T Spear.   

Abstract

OBJECTIVES: To identify a substance found in female genital tract secretions that enhances HIV expression in infected cells.
DESIGN: Cervico-vaginal lavages (CVL), collected in sterile normal saline, were fractionated and tested for HIV-inducing activity using HIV-infected monocytes.
METHODS: To purify the component(s) of CVL that enhance HIV production, Mono-Q ion exchange chromatography followed by Superose-12 molecular sieve analysis, and SDS--PAGE were performed. The purified protein was identified by amino acid sequence analysis.
RESULTS: SDS--PAGE of bioactive fractions showed a 14 kDa polypeptide band. Amino acid sequence analysis of selected peptides from the 14 kDa band showed 100% homology with the myeloid-related protein (MRP)-8, an inflammatory protein found in mucosal secretions. Western blot analysis revealed that bioactive CVL contained more immunoreactive MRP-8 than samples without bioactivity. The HIV-inducing activity of MRP-8 was further confirmed by showing that human recombinant MRP-8 increased HIV expression by up to 40-fold.
CONCLUSIONS: MRP-8 in cervico-vaginal secretions stimulates HIV production. Strategies aimed at blocking MRP-8 activity in the genital tract could reduce risk of sexual as well as maternal--infant transmission of HIV.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11242140     DOI: 10.1097/00002030-200103090-00002

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  7 in total

Review 1.  Cytokines in the host response to Candida vaginitis: Identifying a role for non-classical immune mediators, S100 alarmins.

Authors:  Junko Yano; Mairi C Noverr; Paul L Fidel
Journal:  Cytokine       Date:  2011-12-17       Impact factor: 3.861

2.  HIV-inducing factor in cervicovaginal secretions is associated with bacterial vaginosis in HIV-1-infected women.

Authors:  Jonathan A Cohn; Farhad B Hashemi; Margaret Camarca; Fanhui Kong; Jiahong Xu; Suzanne K Beckner; Andrea A Kovacs; Patricia S Reichelderfer; Gregory T Spear
Journal:  J Acquir Immune Defic Syndr       Date:  2005-07-01       Impact factor: 3.731

3.  Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies.

Authors:  Mimi Ghosh; John V Fahey; Zheng Shen; Timothy Lahey; Susan Cu-Uvin; Zhijin Wu; Kenneth Mayer; Peter F Wright; John C Kappes; Christina Ochsenbauer; Charles R Wira
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

4.  Macrophage secretome from women with HIV-associated neurocognitive disorders.

Authors:  Krystal Colon; Juliana Perez-Laspiur; Raymond Quiles; Yolanda Rodriguez; Valerie Wojna; Scott A Shaffer; John Leszyk; Richard L Skolasky; Loyda M Melendez
Journal:  Proteomics Clin Appl       Date:  2015-11-18       Impact factor: 3.494

5.  Lower levels of HIV-2 than HIV-1 in the female genital tract: correlates and longitudinal assessment of viral shedding.

Authors:  Stephen E Hawes; Papa Salif Sow; Joshua E Stern; Cathy W Critchlow; Geoffrey S Gottlieb; Nancy B Kiviat
Journal:  AIDS       Date:  2008-11-30       Impact factor: 4.177

Review 6.  HIV-Enhancing and HIV-Inhibiting Properties of Cationic Peptides and Proteins.

Authors:  Alexander M Cole; Amy L Cole
Journal:  Viruses       Date:  2017-05-15       Impact factor: 5.048

7.  S100A8-mediated metabolic adaptation controls HIV-1 persistence in macrophages in vivo.

Authors:  Fernando Real; Aiwei Zhu; Boxin Huang; Ania Belmellat; Alexis Sennepin; Thomas Vogl; Céline Ransy; Marc Revol; Riccardo Arrigucci; Anne Lombès; Johannes Roth; Maria Laura Gennaro; Frédéric Bouillaud; Sarra Cristofari; Morgane Bomsel
Journal:  Nat Commun       Date:  2022-10-11       Impact factor: 17.694

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.